160 related articles for article (PubMed ID: 30395685)
21. A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.
Yu L; Baxter PA; Zhao X; Liu Z; Wadhwa L; Zhang Y; Su JM; Tan X; Yang J; Adesina A; Perlaky L; Hurwitz M; Idamakanti N; Police SR; Hallenbeck PL; Blaney SM; Chintagumpala M; Hurwitz RL; Li XN
Neuro Oncol; 2011 Jan; 13(1):14-27. PubMed ID: 21075780
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
Yang F; Zhu Z; Cao W; Liu H; Zhang K; Tian H; Liu X; Zheng H
Vaccine; 2018 Feb; 36(6):841-846. PubMed ID: 29310900
[TBL] [Abstract][Full Text] [Related]
23. Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
Rudin CM; Poirier JT; Senzer NN; Stephenson J; Loesch D; Burroughs KD; Reddy PS; Hann CL; Hallenbeck PL
Clin Cancer Res; 2011 Feb; 17(4):888-95. PubMed ID: 21304001
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of a real-time RT-PCR and a field-deployable RT-insulated isothermal PCR for the detection of Seneca Valley virus.
Zhang J; Nfon C; Tsai CF; Lee CH; Fredericks L; Chen Q; Sinha A; Bade S; Harmon K; Piñeyro P; Gauger P; Tsai YL; Wang HT; Lee PA
BMC Vet Res; 2019 May; 15(1):168. PubMed ID: 31126297
[TBL] [Abstract][Full Text] [Related]
25. Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid.
Strauss M; Jayawardena N; Sun E; Easingwood RA; Burga LN; Bostina M
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263256
[TBL] [Abstract][Full Text] [Related]
26. RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication.
Li P; Zhang X; Cao W; Yang F; Du X; Shi Z; Zhang M; Liu X; Zhu Z; Zheng H
Virol J; 2018 Oct; 15(1):162. PubMed ID: 30352599
[TBL] [Abstract][Full Text] [Related]
27. Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity.
Liu F; Wang Q; Huang Y; Wang N; Shan H
Virus Res; 2021 Jan; 292():198232. PubMed ID: 33207264
[TBL] [Abstract][Full Text] [Related]
28. Generation and diagnostic application of monoclonal antibodies against Seneca Valley virus.
Yang M; van Bruggen R; Xu W
J Vet Diagn Invest; 2012 Jan; 24(1):42-50. PubMed ID: 22362934
[TBL] [Abstract][Full Text] [Related]
29. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
Corbett V; Hallenbeck P; Rychahou P; Chauhan A
Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
[TBL] [Abstract][Full Text] [Related]
30. Seneca Valley Virus 2C and 3C
Liu T; Li X; Wu M; Qin L; Chen H; Qian P
Front Microbiol; 2019; 10():1202. PubMed ID: 31191506
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
32. Experimental Seneca Valley virus infection in market-weight gilts.
Buckley A; Kulshreshtha V; van Geelen A; Montiel N; Guo B; Yoon KJ; Lager K
Vet Microbiol; 2019 Apr; 231():7-10. PubMed ID: 30955826
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary analysis of 3 isolates of Seneca Valley virus from a single pig farm.
Dong J; Rao D; Geng X; Chen M; He S; Jiao F; Huang L; Chen B; Zhao P; Cong F
Can J Vet Res; 2022 Apr; 86(2):102-107. PubMed ID: 35388228
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNAs are associated with Seneca Valley virus infection.
Zhu M; Cai Y; Zhao W; He C; Yang Y; Gao Q; Su S
Vet Microbiol; 2020 Jul; 246():108728. PubMed ID: 32605750
[TBL] [Abstract][Full Text] [Related]
35. Intercellular transmission of Seneca Valley virus mediated by exosomes.
Xu G; Xu S; Shi X; Shen C; Hao J; Yan M; Zhang D; Zhu Z; Zhang K; Zheng H; Liu X
Vet Res; 2020 Jul; 51(1):91. PubMed ID: 32678013
[TBL] [Abstract][Full Text] [Related]
36. The Distribution of Different Clades of Seneca Valley Viruses in Guangdong Province, China.
Chen P; Yang F; Cao W; Liu H; Zhang K; Liu X; Xu Z; Zhu Z; Zheng H
Virol Sin; 2018 Oct; 33(5):394-401. PubMed ID: 30328012
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic virotherapy.
Sze DY; Reid TR; Rose SC
J Vasc Interv Radiol; 2013 Aug; 24(8):1115-22. PubMed ID: 23885911
[TBL] [Abstract][Full Text] [Related]
38. Isolation and full-genome sequencing of Seneca Valley virus in piglets from China, 2016.
Qian S; Fan W; Qian P; Chen H; Li X
Virol J; 2016 Oct; 13(1):173. PubMed ID: 27756396
[TBL] [Abstract][Full Text] [Related]
39. A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials.
Matsuda T; Karube H; Aruga A
Ther Innov Regul Sci; 2018 Jul; 52(4):430-437. PubMed ID: 29714547
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
Yamaguchi T; Uchida E
Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
